Role of Dok-1 and Dok-2 in Leukemia Suppression
Open Access
- 20 December 2004
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 200 (12) , 1689-1695
Abstract
Chronic myelogenous leukemia (CML) is characterized by the presence of the chimeric p210bcr/abl oncoprotein that shows elevated and constitutive protein tyrosine kinase activity relative to the normal c-abl tyrosine kinase. Although several p210bcr/abl substrates have been identified, their relevance in the pathogenesis of the disease is unclear. We have identified a family of proteins, Dok (downstream of tyrosine kinase), coexpressed in hematopoietic progenitor cells. Members of this family such as p62dok(Dok-1) and p56dok-2(Dok-2) associate with the p120 rasGTPase-activating protein (rasGAP) upon phosphorylation by p210bcr/abl as well as receptor and nonreceptor tyrosine kinases. Here, we report the generation and characterization of single and double Dok-1 or Dok-2 knockout (KO) mutants. Single KO mice displayed normal steady-state hematopoiesis. By contrast, concomitant Dok-1 and Dok-2 inactivation resulted in aberrant hemopoiesis and Ras/MAP kinase activation. Strikingly, all Dok-1/Dok-2 double KO mutants spontaneously developed transplantable CML-like myeloproliferative disease due to increased cellular proliferation and reduced apoptosis. Furthermore, Dok-1 or Dok-2 inactivation markedly accelerated leukemia and blastic crisis onset in Tec-p210bcr/abl transgenic mice known to develop, after long latency, a myeloproliferative disorder resembling human CML. These findings unravel the critical and unexpected role of Dok-1 and Dok-2 in tumor suppression and control of the hematopoietic compartment homeostasis.Keywords
This publication has 20 references indexed in Scilit:
- Studying the pathogenesis of BCR–ABL+ leukemia in miceOncogene, 2002
- Modeling Philadelphia chromosome positive leukemiasOncogene, 2001
- P62dok, a Negative Regulator of Ras and Mitogen-Activated Protein Kinase (Mapk) Activity, Opposes Leukemogenesis by P210bcr-ablJournal of Experimental Medicine, 2001
- Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiationJournal of Cell Biology, 2001
- Chronic Myelogenous LeukemiaHematology-American Society Hematology Education Program, 2001
- p56dok‐2 as a cytokine‐inducible inhibitor of cell proliferation and signal transductionThe EMBO Journal, 2000
- Molecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding ProteinsJournal of Biological Chemistry, 1998
- Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for RasOncogene, 1997
- Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, DokCell, 1997
- p62 : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor CellsCell, 1997